James R. Patrinely

6.5k total citations
141 papers, 3.4k citations indexed

About

James R. Patrinely is a scholar working on Surgery, Dermatology and Ophthalmology. According to data from OpenAlex, James R. Patrinely has authored 141 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Surgery, 37 papers in Dermatology and 35 papers in Ophthalmology. Recurrent topics in James R. Patrinely's work include Facial Rejuvenation and Surgery Techniques (21 papers), Facial Trauma and Fracture Management (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). James R. Patrinely is often cited by papers focused on Facial Rejuvenation and Surgery Techniques (21 papers), Facial Trauma and Fracture Management (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). James R. Patrinely collaborates with scholars based in United States, Australia and France. James R. Patrinely's co-authors include Charles N. S. Soparkar, Richard L. Anderson, W. D. Appling, Ramon L. Font, Douglas B. Johnson, David R. Jordan, John B. Holds, Stephen R. Klapper, Robert C. Kersten and Andrew G. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

James R. Patrinely

137 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Patrinely United States 32 1.5k 1.0k 617 593 538 141 3.4k
Aaron Fay United States 23 772 0.5× 462 0.5× 274 0.4× 282 0.5× 240 0.4× 96 1.9k
William R. Panje United States 29 1.2k 0.8× 284 0.3× 126 0.2× 535 0.9× 338 0.6× 91 2.4k
Hakan Demirci United States 39 784 0.5× 3.3k 3.3× 652 1.1× 1.3k 2.2× 367 0.7× 232 5.5k
Lawrence E. Ginsberg United States 41 1.8k 1.2× 145 0.1× 176 0.3× 1.5k 2.5× 502 0.9× 150 4.8k
Jan L. Kasperbauer United States 47 3.3k 2.1× 233 0.2× 126 0.2× 1.7k 2.8× 253 0.5× 186 6.8k
Stanley M. Shapshay United States 45 2.3k 1.5× 169 0.2× 288 0.5× 841 1.4× 73 0.1× 187 5.5k
Daniel G. Deschler United States 32 2.7k 1.8× 162 0.2× 126 0.2× 1.9k 3.1× 279 0.5× 231 5.6k
Michael K. Yoon United States 20 400 0.3× 428 0.4× 191 0.3× 114 0.2× 237 0.4× 141 1.3k
Lauren V. Ackerman United States 40 1.9k 1.3× 123 0.1× 332 0.5× 1.8k 3.1× 529 1.0× 102 5.7k
O Blétry France 37 857 0.6× 341 0.3× 146 0.2× 106 0.2× 407 0.8× 215 4.1k

Countries citing papers authored by James R. Patrinely

Since Specialization
Citations

This map shows the geographic impact of James R. Patrinely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Patrinely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Patrinely more than expected).

Fields of papers citing papers by James R. Patrinely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Patrinely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Patrinely. The network helps show where James R. Patrinely may publish in the future.

Co-authorship network of co-authors of James R. Patrinely

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Patrinely. A scholar is included among the top collaborators of James R. Patrinely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Patrinely. James R. Patrinely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodman, Rachel, Aleigha Lawless, Rachel Woodford, et al.. (2023). Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma. JAMA Network Open. 6(8). e2327145–e2327145. 30 indexed citations
2.
Serra-Bellver, Patricio, Judith M. Versluis, Cong Zhou, et al.. (2022). Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study. European Journal of Cancer. 176. 121–132. 14 indexed citations
3.
Johannet, Paul, Nicolas Coudray, Douglas M. Donnelly, et al.. (2020). Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma. Clinical Cancer Research. 27(1). 131–140. 114 indexed citations
4.
Johnson, Douglas B., Kerry L. Reynolds, Ryan J. Sullivan, et al.. (2020). Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research. The Lancet Oncology. 21(8). e398–e404. 78 indexed citations
5.
Patrinely, James R., et al.. (2020). Outcomes after progression of disease with anti–PD‐1/PD‐L1 therapy for patients with advanced melanoma. Cancer. 126(15). 3448–3455. 23 indexed citations
6.
Patrinely, James R., et al.. (2020). Risk of adverse events due to high volumes of local anesthesia during Mohs micrographic surgery. Archives of Dermatological Research. 313(8). 679–684. 3 indexed citations
7.
Brown, Lauren, Alison M. Weppler, Prachi Bhave, et al.. (2020). Combination anti-PD-1 and ipilimumab (ipi) therapy in patients with advanced melanoma and pre-existing autoimmune disorders (AD).. Journal of Clinical Oncology. 38(15_suppl). 10026–10026. 3 indexed citations
8.
Soparkar, Charles N. S., et al.. (2007). Eyelid Edema. Seminars in Plastic Surgery. 21(1). 24–31. 10 indexed citations
9.
Soparkar, Charles N. S., et al.. (2007). Perspectives on Periocular Asymmetry. Seminars in Plastic Surgery. 21(1). 18–23. 7 indexed citations
10.
Soparkar, Charles N. S., et al.. (2004). Erasing Restylane. Ophthalmic Plastic and Reconstructive Surgery. 20(4). 317–318. 63 indexed citations
11.
Soparkar, Charles N. S., et al.. (2000). Growth Factors Embedded in an Agarose Matrix Enhance the Rate of Porous Polyethylene Implant Biointegration. Ophthalmic Plastic and Reconstructive Surgery. 16(5). 341–346. 12 indexed citations
12.
Davidson, J. K., Charles N. S. Soparkar, J. B. Williams, & James R. Patrinely. (1999). Negative Sinus Pressure and Normal Predisease Imaging in Silent Sinus Syndrome. Archives of Ophthalmology. 117(12). 1653–1653. 77 indexed citations
13.
Soparkar, Charles N. S. & James R. Patrinely. (1998). Eyelid cancers. Current Opinion in Ophthalmology. 9(5). 49–53. 3 indexed citations
14.
Klapper, Stephen R., et al.. (1997). Orbital Involvement in Allergic Fungal Sinusitis. Ophthalmology. 104(12). 2094–2100. 43 indexed citations
15.
Beaver, Hilary A., et al.. (1996). Periocular Autografts in Socket Reconstruction. Ophthalmology. 103(9). 1498–1502. 19 indexed citations
16.
Cowen, David, Oleh Antonyshyn, James R. Patrinely, Richard L. Anderson, & Louis Morales. (1995). The Vascularized Temporoparietal Fascial Flap for Correction of the Deep Superior Sulcus. Ophthalmic Plastic and Reconstructive Surgery. 11(2). 100–108. 7 indexed citations
17.
Patrinely, James R., et al.. (1993). Primary Basal Cell Carcinoma of the Limbal Conjunctiva. Ophthalmology. 100(11). 1720–1722. 15 indexed citations
18.
Jordan, David R., et al.. (1992). Complications Associated with Alloplastic Implants used in Orbital Fracture Repair. Ophthalmology. 99(10). 1600–1608. 141 indexed citations
19.
Patrinely, James R., et al.. (1987). Hemifacial Spasm. Ophthalmology. 94(3). 288–294. 17 indexed citations
20.
Patrinely, James R. & R. L. Anderson. (1986). The Septal Pulley in Frontalis Suspension. Archives of Ophthalmology. 104(11). 1707–1710. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026